[go: up one dir, main page]

MX2015001670A - Eprotirom para uso en la prevencion y/o tratamiento de trastornos del cabello y composiciones del mismo. - Google Patents

Eprotirom para uso en la prevencion y/o tratamiento de trastornos del cabello y composiciones del mismo.

Info

Publication number
MX2015001670A
MX2015001670A MX2015001670A MX2015001670A MX2015001670A MX 2015001670 A MX2015001670 A MX 2015001670A MX 2015001670 A MX2015001670 A MX 2015001670A MX 2015001670 A MX2015001670 A MX 2015001670A MX 2015001670 A MX2015001670 A MX 2015001670A
Authority
MX
Mexico
Prior art keywords
eprotirome
hair
prevention
compositions
treatment
Prior art date
Application number
MX2015001670A
Other languages
English (en)
Other versions
MX350125B (es
Inventor
Michael Soeberdt
Christoph Abels
Ulrich Knie
Original Assignee
Wolff August Gmbh & Co Kg Arzneimittel Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolff August Gmbh & Co Kg Arzneimittel Dr filed Critical Wolff August Gmbh & Co Kg Arzneimittel Dr
Publication of MX2015001670A publication Critical patent/MX2015001670A/es
Publication of MX350125B publication Critical patent/MX350125B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona métodos para prevenir y/o tratar trastornos del cabello, en particular para prevenir y/o tratar cabello canoso y pérdida del cabello, incluyendo detener y/o revertir la pérdida del cabello y promover el crecimiento del cabello, en un mamífero, así como composiciones farmacéuticas que contienen eprotirom como ingrediente activo.
MX2015001670A 2012-08-06 2013-08-05 Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo. MX350125B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261679990P 2012-08-06 2012-08-06
EP12179384.8A EP2695611B1 (en) 2012-08-06 2012-08-06 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
PCT/EP2013/066409 WO2014023698A1 (en) 2012-08-06 2013-08-05 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof

Publications (2)

Publication Number Publication Date
MX2015001670A true MX2015001670A (es) 2015-04-10
MX350125B MX350125B (es) 2017-08-28

Family

ID=46963380

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015001670A MX350125B (es) 2012-08-06 2013-08-05 Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo.

Country Status (16)

Country Link
US (1) US20150182482A1 (es)
EP (1) EP2695611B1 (es)
JP (1) JP6125012B2 (es)
KR (1) KR20150039824A (es)
CN (1) CN104717964A (es)
AU (1) AU2013301601B2 (es)
BR (1) BR112015002540A2 (es)
CA (1) CA2879847C (es)
DK (1) DK2695611T3 (es)
ES (1) ES2528392T3 (es)
HK (1) HK1206598A1 (es)
MX (1) MX350125B (es)
PL (1) PL2695611T3 (es)
RU (1) RU2015107846A (es)
SG (1) SG11201500838UA (es)
WO (1) WO2014023698A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552782A1 (en) 2019-05-08 2023-01-16 Aligos Therapeutics Inc Modulators of thr-㟠and methods of use thereof
CN111110600B (zh) * 2019-12-31 2021-08-06 泉后(深圳)信息技术有限公司 一种头皮净化促生发组合物及其乳液
JP2025501641A (ja) * 2021-12-29 2025-01-22 リビウス プライベート リミテッド ｍｉＲ－５２０ｄ－５ｐを利用したヘアサイクル関連遺伝子の修復方法及びヘアサイクル関連疾患の処置方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580550B1 (en) * 1992-07-21 1997-10-22 Novartis AG Oxamic acid derivatives as hypocholesteremic agents
AU4990496A (en) 1995-02-23 1996-09-11 Life Medical Sciences, Inc. Compositions and methods for enhancing the growth of hair and restoring hair color
AR018472A1 (es) 1999-06-01 2001-11-14 Procter & Gamble Compuesto, composicion y metodo para el tratamiento de la perdida de cabello
MXPA01012496A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Compuestos de biarilo.
MXPA01012493A (es) 1999-06-01 2003-09-10 Univ Texas Southwestern Med Ct Metodo para tratar la perdida capilar con el uso de derivados de eter difenilico.
WO2000072811A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss
JP2003500433A (ja) * 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ジフェニルメタン誘導体を用いる脱毛の処置方法
WO2000072810A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
CZ20022771A3 (cs) 2000-02-17 2003-09-17 Bristol-Myers Squibb Company Ligandy thyreoidního receptoru odvozené od anilinu
HUP0300329A3 (en) 2000-03-31 2004-08-30 Pfizer Prod Inc Malonamic acids and derivatives and use thereof as thyroid receptor ligands and for preparation of pharmaceutical compositions containing them
ES2267945T3 (es) 2001-05-31 2007-03-16 Pfizer Products Inc. Uso medico de compuestos tiromimeticos para tratar la perdida del cabello y composiciones.
ES2253495T3 (es) 2001-09-26 2006-06-01 Pfizer Products Inc. Acidos indol carboxilicos como ligandos de receptores tiroideos.
US6806381B2 (en) 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
US7230031B2 (en) 2002-01-30 2007-06-12 Kissei Pharmaceutical Co., Ltd. Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
JP4810151B2 (ja) 2005-07-22 2011-11-09 出光興産株式会社 イネの育苗時期に発生する病害に対する防除剤
US7812299B2 (en) 2005-07-22 2010-10-12 Nikon Corporation Image sensor having two-dimensionally arrayed pixels, focus detecting device using the sensor, and imaging system including the sensor
GB0606201D0 (en) 2006-03-28 2006-05-10 Karobio Ab Improved crytalline material
CA2655913A1 (en) 2006-06-28 2008-01-03 Sanwa Kagaku Kenkyusho Co., Ltd. Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility
GB0724478D0 (en) 2007-12-14 2008-01-30 Karobio Ab Pharmaceutical compositions
GB0725214D0 (en) 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
JP2009155261A (ja) 2007-12-26 2009-07-16 Sanwa Kagaku Kenkyusho Co Ltd 新規インドール誘導体及びその医薬用途
EP2609910A1 (en) * 2011-12-30 2013-07-03 Deva Holding Anonim Sirketi Formulations of eprotirome

Also Published As

Publication number Publication date
CA2879847A1 (en) 2014-02-13
CN104717964A (zh) 2015-06-17
BR112015002540A2 (pt) 2017-12-12
AU2013301601A1 (en) 2015-02-05
WO2014023698A1 (en) 2014-02-13
US20150182482A1 (en) 2015-07-02
CA2879847C (en) 2017-10-03
JP6125012B2 (ja) 2017-05-10
SG11201500838UA (en) 2015-03-30
AU2013301601B2 (en) 2016-09-01
HK1206598A1 (en) 2016-01-15
EP2695611B1 (en) 2014-10-01
KR20150039824A (ko) 2015-04-13
ES2528392T3 (es) 2015-02-09
PL2695611T3 (pl) 2015-03-31
DK2695611T3 (en) 2015-01-05
MX350125B (es) 2017-08-28
RU2015107846A (ru) 2016-09-27
EP2695611A1 (en) 2014-02-12
JP2015524458A (ja) 2015-08-24

Similar Documents

Publication Publication Date Title
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
MX394909B (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos
MX365939B (es) Moduladores del transporte nuclear y usos de los mismos.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
NZ702663A (en) Nuclear transport modulators and uses thereof
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
EA033374B9 (ru) Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
MX353942B (es) Sistemas para el cuidado de la piel después del procedimiento, composiciones y métodos de uso de los mismos.
NZ729252A (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
WO2012158672A3 (en) Compounds for use in treatment of mucositis
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX350125B (es) Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2013038200A3 (en) Neurodevelopmental disorders
WO2012170664A3 (en) Methods of cancer treatment and prevention through the modulation of sirt4 activity
MX2018015240A (es) Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
WO2014082738A8 (en) Heteroquinoline-3-carboxamides as kcnq2/3 modulators
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci
HK1215375A1 (zh) 阿克曼氏菌用於治療代謝病症的用途

Legal Events

Date Code Title Description
FG Grant or registration